Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Autor: Douillard, J.Y. *, Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., Rivera, F., Kocákova, I., Ruff, P., Błasińska-Morawiec, M., Šmakal, M., Canon, J.L., Rother, M., Oliner, K.S., Tian, Y., Xu, F., Sidhu, R.
Zdroj: In Annals of Oncology July 2014 25(7):1346-1355
Databáze: ScienceDirect